IGC Pharma (IGC) Long-Term Deferred Tax (2011 - 2016)
IGC Pharma (IGC) reported Long-Term Deferred Tax of $19000.0 for Q4 2016, down 93.76% year-over-year from $304272.0 in Q1 2016, and down 94.67% quarter-over-quarter from $356619.0 in Q3 2016.
IGC Pharma (IGC) Long-Term Deferred Tax (2011 - 2016) Analysis & Trends
IGC Pharma (IGC) has 6 years of Long-Term Deferred Tax data on file, last reported at $19000.0 in Q4 2016.
- Long-Term Deferred Tax for Q4 2016 came in at $19000.0, down 93.76% year-over-year; the trailing twelve-month figure through Dec 2016 was $19000.0 (down 93.76% YoY), and the FY2016 annual result was $356684.0, up 11.97% from the prior year.
- Long-Term Deferred Tax retreated to $19000.0 in Q4 2016 per IGC's latest filing, from $356619.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $356684.0 in Q1 2016 and troughed at -$14076.0 in Q1 2012.
- A 5-year average of $287677.3 and a median of $318548.0 in 2015 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2013 and 2016: Long-Term Deferred Tax soared 2525.8% in 2013, then plunged 93.76% in 2016.
- A 5-year view of Long-Term Deferred Tax shows it stood at -$14076.0 in 2012, then jumped by 2221.59% to $298635.0 in 2013, then increased by 6.54% to $318159.0 in 2014, then dropped by 4.36% to $304272.0 in 2015, then sank by 93.76% to $19000.0 in 2016.
- Business Quant data shows IGC's Long-Term Deferred Tax at $19000.0 in Q4 2016, $356619.0 in Q3 2016, and $356334.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 19,000.00 |
| Sep 30, 2016 | 356,619.00 |
| Jun 30, 2016 | 356,334.00 |
| Mar 31, 2016 | 356,684.00 |
| Dec 31, 2015 | 304,272.00 |
| Sep 30, 2015 | 311,509.00 |
| Jun 30, 2015 | 318,153.00 |
| Mar 31, 2015 | 318,548.00 |
| Dec 31, 2014 | 318,159.00 |
| Sep 30, 2014 | 318,625.00 |
| Jun 30, 2014 | 322,451.00 |
| Mar 31, 2014 | 321,676.00 |
| Dec 31, 2013 | 298,635.00 |
| Sep 30, 2013 | 316,233.00 |
| Jun 30, 2013 | 326,237.00 |
| Mar 31, 2013 | 341,455.00 |
| Mar 31, 2012 | -14,076.00 |
| Dec 31, 2011 | 180,929.00 |